Literature DB >> 1694889

Membrane and cytosolic interleukin-1 alpha and beta in normal human epidermal cells: variability of epitope exposure in immunohistochemistry.

H S Anttila1, S Reitamo, P Erkko, A Miettinen, L Didierjean, J H Saurat.   

Abstract

Previous studies have shown that interleukin-1 (IL-1) is present in normal human epidermis. However, with immunohistochemical techniques, epidermal IL-1 immunoreactivity has been found in only a limited number of epidermal cells. In the present study, we show that both IL-1 alpha and beta immunoreactivities can be detected in all epidermal cell layers, provided optimal processing of tissue samples is used. The use of isolated epidermal cells showed that keratinocytes at various stages of maturation display both membrane-associated and cytosolic IL-1 alpha and beta immunoreactivities. After protease treatment of tissue sections, the IL-1 beta immunoreactivity of the granular cell layer was enhanced by some antibodies used, whereas in the other cell layers it was clearly lower. We a) suggest a different cellular localization, processing, and/or binding to subcellular structures of IL-1 during the differentiation process of human keratinocytes and b) outline the technical difficulties in any immunohistologic approach to IL-1 status in diseased skin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694889     DOI: 10.1111/1523-1747.ep12873278

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  Immunohistochemical localization of IL-1 alpha-, IL-1 beta-, IL-6- and TNF-alpha-like immunoreactivities in human apocrine glands.

Authors:  A A Ahmed; K Nordlind; M Schultzberg; S Lidén
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

2.  Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that IL-1-inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease.

Authors:  R W Groves; T Rauschmayr; K Nakamura; S Sarkar; I R Williams; T S Kupper
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

3.  Enhanced epithelial proliferation due to elevated levels of interleukin-1 receptors in middle ear cholesteatomas.

Authors:  J Bujia; C Kim; P Ostos-Aumente; J Lopez-Villarejo; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

4.  Interleukin-1 receptor antagonist in normal and psoriatic epidermis.

Authors:  C Hammerberg; W P Arend; G J Fisher; L S Chan; A E Berger; J S Haskill; J J Voorhees; K D Cooper
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

5.  The cytokines NAP-1 (IL-8), MCP-1, IL-1 beta, and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard.

Authors:  J Tsuruta; K Sugisaki; A M Dannenberg; T Yoshimura; Y Abe; P Mounts
Journal:  Inflammation       Date:  1996-06       Impact factor: 4.092

6.  The Coagulation and Immune Systems Are Directly Linked through the Activation of Interleukin-1α by Thrombin.

Authors:  Laura C Burzynski; Melanie Humphry; Katerina Pyrillou; Kimberley A Wiggins; Julie N E Chan; Nichola Figg; Lauren L Kitt; Charlotte Summers; Kate C Tatham; Paul B Martin; Martin R Bennett; Murray C H Clarke
Journal:  Immunity       Date:  2019-03-26       Impact factor: 31.745

Review 7.  Alternative Pathways of IL-1 Activation, and Its Role in Health and Disease.

Authors:  Katerina Pyrillou; Laura C Burzynski; Murray C H Clarke
Journal:  Front Immunol       Date:  2020-12-18       Impact factor: 7.561

Review 8.  Interleukin-1 Inhibitors and Vaccination Including COVID-19 in Inflammatory Rheumatic Diseases: A Nonsystematic Review.

Authors:  Pamir Atagündüz; Gökhan Keser; Mehmet Soy
Journal:  Front Immunol       Date:  2022-01-27       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.